Oragenics (NYSE:OGEN) Now Covered by StockNews.com
Oragenics (NYSE:OGEN) Now Covered by StockNews.com
Stock analysts at StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Get Rating) in a research report issued on Thursday. The firm set a "sell" rating on the stock.
Oragenics Price Performance
NYSE OGEN opened at $3.43 on Thursday. The business has a fifty day moving average price of $4.71 and a two-hundred day moving average price of $1.90. The stock has a market capitalization of $6.72 million, a PE ratio of -0.44 and a beta of 0.37. Oragenics has a fifty-two week low of $2.61 and a fifty-two week high of $24.00.
Get Oragenics alerts:About Oragenics
(Get Rating)
Oragenics, Inc develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.
Further Reading
- Get a free copy of the StockNews.com research report on Oragenics (OGEN)
- Penny Stock Wag! Group Co. Has Solid Sell-Side Support
- Staples Stocks Get Lift From Conagra Results, New Highs In Sight
- SGH Bottomed, But Can It Reverse And Move Higher?
- Is Pinterest Showing Signs of an Improving Ad Market?
- At 3x Earnings, Avis Budget Is Worth Taking for a Spin
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
Stock analysts at StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Get Rating) in a research report issued on Thursday. The firm set a "sell" rating on the stock.
StockNews.com的股票分析師開始報道以下股票 Oragenics(紐約證券交易所代碼:OGEN — 獲取評級) 在週四發佈的研究報告中。該公司對該股設定了 “賣出” 評級。
Oragenics Price Performance
Oragenics 價格表現
NYSE OGEN opened at $3.43 on Thursday. The business has a fifty day moving average price of $4.71 and a two-hundred day moving average price of $1.90. The stock has a market capitalization of $6.72 million, a PE ratio of -0.44 and a beta of 0.37. Oragenics has a fifty-two week low of $2.61 and a fifty-two week high of $24.00.
紐約證券交易所OGEN週四開盤價爲3.43美元。該公司的五十天移動平均價格爲4.71美元,兩百天移動平均線價格爲1.90美元。該股的市值爲672萬美元,市盈率爲-0.44,beta值爲0.37。Oragenics創下五十二週低點2.61美元,五十二週高點爲24.00美元。
About Oragenics
關於 Oragenics
(Get Rating)
(獲取評級)
Oragenics, Inc develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus.
Oragenics, Inc在美國開發用於傳染病的抗生素。該公司參與NT-CoV-2-1(一種提供新型嚴重急性呼吸綜合徵冠狀病毒免疫力的鼻內候選疫苗)的開發和商業化;以及提供對新型嚴重急性呼吸綜合徵冠狀病毒免疫的肌肉注射候選疫苗Terra CoV-2。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on Oragenics (OGEN)
- Penny Stock Wag! Group Co. Has Solid Sell-Side Support
- Staples Stocks Get Lift From Conagra Results, New Highs In Sight
- SGH Bottomed, But Can It Reverse And Move Higher?
- Is Pinterest Showing Signs of an Improving Ad Market?
- At 3x Earnings, Avis Budget Is Worth Taking for a Spin
- 免費獲取 StockNews.com 關於 Oragenics (OGEN) 的研究報告
- Penny Stock Wag集團公司有堅實的賣方支持
- 斯臺普斯股票從康納格拉的業績中獲得提振,新高在望
- SGH 觸底,但它能否逆轉並走高?
- Pinterest 是否顯示出廣告市場改善的跡象?
- Avis Budget 的收益是 3 倍,值得一試
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Oragenics Daily 的新聞和評級 -在下面輸入您的電子郵件地址,即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Oragenics及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧